title: [Drug-drug interactions with HIV treatments].
abstract: We develop a differential diagnosis and diagnostic approach to a possible drug-drug interaction between a cART based on boosted atazanavir and newly given drugs. History taking should not only encompass prescribed but also over-the-counter medication. Exchange of information between attending physicians as to therapeutic changes, documented side effects and adherence, therapeutic drug monitoring of cART and evaluation by pharmacologist in complex situations are the diagnostic tools at hand.
authors.affiliation: Klinik für Infektiologie und Spitalhygiene, Universitätsspital Basel. mossdorfe@gmx.ch
authors.forename: E
authors.initials: E
authors.lastname: Mossdorf
authors.forename: C
authors.initials: C
authors.lastname: Marzolini
authors.forename: D
authors.initials: D
authors.lastname: Fasel
authors.forename: A
authors.initials: A
authors.lastname: Mello Fayet
authors.forename: C
authors.initials: C
authors.lastname: Blum
authors.forename: M
authors.initials: M
authors.lastname: Donath
authors.forename: M
authors.initials: M
authors.lastname: Battegay
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic
chemical_list: D019380:Anti-HIV Agents; D007004:Hypoglycemic Agents